Biocytogen Secures $5 Million Milestone as IDEAYA Doses First Patient in Phase 1 Trial of Bispecific ADC IDE034

IDE034 is a B7H3/PTK7 bispecific TOP1 ADC designed to target tumor cells expressing both B7H3 and PTK7 preferentially, and is being evaluated as mono...

March 02, 2026 | Monday | News
Fangzhou and Youcare Forge Strategic AI Partnership to Advance Digital Chronic Disease Management in China

Fangzhou Inc. (“Fangzhou” or the “Company”) (HKEX: 06086), a leading provider of AI-driven Internet healthcare solutions, has sig...

March 02, 2026 | Monday | News
Designing Decarbonization: Embedding Sustainability at the Core of Life Sciences Infrastructure

As life sciences companies scale biologics, advanced therapies, and personalized medicines, sustainability has moved from aspiration to operational imperat...

February 27, 2026 | Friday | News
GSK Expands Immunology Pipeline Through siRNA Licensing Agreement with Frontier Biotech

Frontier Biotechnologies Inc. (hereinafter referred to as "Frontier Biotech" or "the Company") has entered into an exclusive licensing agreemen...

February 26, 2026 | Thursday | News
PacBio and DNAstack Unite to Accelerate Rare Disease Discovery Through Federated HiFi Sequencing

PacBio (NASDAQ: PACB), developer of the world’s most advanced sequencing technologies,  announced a collaboration with DNAstack to power the wor...

February 26, 2026 | Thursday | News
Bayer Sues Johnson & Johnson And Janssen Biotech Over Allegedly Misleading Prostate Cancer Drug Data

Bayer files false advertising suit against J&J and Janssen Biotech Lawsuit seeks preliminary and permanent injunctions in addition to damages. ...

February 25, 2026 | Wednesday | News
ImmunityBio Expands Global Footprint with ANKTIVA Commercialization Partnership in Middle East

Biopharma & Cigalah are two of the largest pharmaceutical commercial distributors in the Middle East and North Africa (MENA) ImmunityBio establi...

February 24, 2026 | Tuesday | News
Dr. Reddy’s Advances Biosimilar Pipeline with FDA Review Acceptance for DRL_AB

Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as “D...

February 24, 2026 | Tuesday | News
Sai Life Sciences Announces Major Talent Expansion as Global Outsourcing Momentum Accelerates

Sai Life Sciences Limited (BSE: 544306 | NSE: SAILIFE), one of India’s leading integrated contract research, development and manufacturing organiza...

February 24, 2026 | Tuesday | News
Savara Advances MOLBREEVI Toward Approval with FDA Priority Review and 2026 Decision Timeline

Priority Review Granted, Prescription Drug User Fee Act (PDUFA) Target Action Date Set for August 22, 2026 -- -- Company Plans to Submit the MOLBREEV...

February 24, 2026 | Tuesday | News
Stellaromics Launches Pyxa™, the First Commercial Platform for Multiplexed 3D Spatial Transcriptomics in Intact Tissue

Stellaromics launched Pyxa™, the first commercially available platform to deliver multiplexed 3D spatial transcriptomics in intact tissue up to 100...

February 23, 2026 | Monday | News
Bio Usawa and Nanoly Bioscience Partner to Revolutionize Biologic and Vaccine Distribution with DynaShield™

Bio Usawa, a leader in expanding global access to biopharmaceuticals, and Nanoly Bioscience, a pioneer in chemical stabilization,  announced a defin...

February 19, 2026 | Thursday | News
Novartis’ Remibrutinib Demonstrates Strong Phase III Efficacy in Chronic Inducible Urticaria

Statistically significant and clinically meaningful results seen in RemIND trial with complete responses achieved in 3 CIndU types1 Remibrutinib, a hi...

February 19, 2026 | Thursday | News
Sapu Bioscience Secures Global IP Fortress for OT-101, Advancing Integrated CNS Platform in Neurology and Oncology

Sapu Bioscience announced advancements in its global IP portfolio supporting OT-101, its proprietary TGF-β antisense therapeutic platform, stre...

February 18, 2026 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close